Marie Nguyen (Roussillon)
About Marie Nguyen (Roussillon)
Marie Nguyen is the Executive Director of ECD Heme/Onc & Cell Therapy and Head of R&ED Clinical Center of Excellence at Bristol Myers Squibb, with extensive experience in hematology and oncology.
Executive Director at Bristol Myers Squibb
Marie Nguyen serves as the Executive Director, Ecd Heme/Onc & Cell Therapy; Head, R&Ed Clinical Center Of Excellence at Bristol Myers Squibb. In this role, she leads initiatives in early clinical development, specifically focusing on hematology, oncology, and cell therapy. Her responsibilities encompass overseeing clinical trials and advancing therapeutic discoveries in these specialized areas.
Previous Roles at Bristol Myers Squibb
Marie Nguyen has held multiple leadership roles at Bristol Myers Squibb before her current position. She was Executive Director, ECD HOCT; Head, ECD HOCT CCoE/Business Operations in 2022 and served as Senior Director, Hematology/Oncology and Cell Therapy, Early Clinical Development from 2019 to 2022. Her work has consistently focused on guiding clinical research and development in oncology and cell therapy.
Experience at Celgene
Before joining Bristol Myers Squibb, Marie Nguyen worked at Celgene in pivotal roles. She was Senior Director, Translational Medicine for seven months in 2019 and served as Senior Medical Director, Clinical R&D from 2018 to 2019. At Celgene, she played a key role in advancing clinical trials and fostering translational research to bridge the gap between laboratory findings and patient care.
Academic Background
Marie Nguyen has extensive academic qualifications from Stanford University. She earned a Master’s in Epidemiology (2011-2013) and Doctor of Medicine (M.D., 2001-2006). Additionally, she holds a Bachelor of Science in Biological Sciences and a Bachelor of Arts in Classical and Ancient Studies, both obtained from Stanford University between 1996 and 2000.
Involvement in Clinical Research and Mentorship
Marie Nguyen has made significant contributions to clinical research and education. She has authored numerous peer-reviewed publications in hematology and oncology and served as a principal investigator in early-phase clinical trials on cell therapy. She received the NIH KL2 Mentored Career Development Award and is actively involved in mentoring junior researchers and clinicians. She has presented her research findings at major international conferences such as ASCO and ASH.